Enhanced susceptibility to superantigen-associated streptococcal sepsis in human leukocyte antigen-DQ transgenic mice

Journal of Infectious Diseases

Volumn 184, Issue 2, 2001, Pages 166-173

  Sriskandan, Shiranee ^a   Unnikrishnan, Meera ^a   Krausz, Thomas ^a   Dewchand, Hamlata ^a   Van Noorden, Susan ^a   Cohen, Jonathan ^a   Altmann, Daniel M ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQ ANTIGEN; STREPTOCOCCUS ANTIGEN; SUPERANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; LYMPHOBLASTOID CELL; MORTALITY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; STRAIN DIFFERENCE; STREPTOCOCCUS PYOGENES; TRANSGENIC MOUSE;

ANIMALS; BACTERIAL PROTEINS; CELL DIVISION; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; EXOTOXINS; GENE EXPRESSION REGULATION; HLA-DQ ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; SEPSIS; SPLEEN; STREPTOCOCCUS PYOGENES; SUPERANTIGENS; T-LYMPHOCYTES;

EID: 0035879688     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/322018     Document Type: Article

References (39)

1. The staphylococcal enterotoxins and their relatives
2. + T cells in mice tolerant to Staphylococcus aureus enterotoxin B
3. + peripheral T cells responding to staphylococcal enterotoxin B in vivo
4. Profound deletion of mature T cells in vivo by chronic exposure to exogenous superantigen
5. Clinical and bacteriologic observations of a toxic shock like syndrome due to Streptococcus pyogenes
6. Defining the group A streptococcal toxic shock syndrome: Rationale and consensus definition
7. Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: Clonal diversity and pyrogenic exotoxin expression
8. Selective expansion of T cells expressing Vβ2 in toxic shock syndrome
9. Streptococcal toxic shock-like syndrome: Evidence of superantigen activity and its effects on T lymphocyte subsets in vivo
10. Selective depletion of Vβ-bearing T cells in patients with severe invasive group A streptococcal infections and streptococcal toxic shock syndrome
11. Detection of circulating bacterial superantigen and lymphotoxin-α in patients with streptococcal toxic-shock syndrome
12. Intravenous immunoglobulin therapy for streptococcal syndrome: A comparative observational study
13. Lymphokine production induced by streptococcal pyrogenic exotoxin A is selectively down-regulated by pooled human IgG
14. HLA-DR alleles differ in their ability to present staphylococcal enterotoxins to T cells
15. Structural basis for the recognition of superantigen streptococcal pyrogenic exotoxin A (SpeA1) by MHC class II molecules and T cell receptors
16. Characterization and clonal distribution of four alleles of the speA gene encoding pyrogenic exotoxin A (scarlet fever toxin) in Streptococcus pyogenes
17. Identification and characterization of novel superantigens from Streptococcus pyogenes
18. Glutamic acid decarboxylase T lymphocyte responses associated with susceptibility or resistance to type I diabetes: Analysis in disease discordant human twins, non-obese diabetic mice, and HLA-DQ transgenic mice
19. The T celt response of HLA-DR transgenic mice to human myelin basic protein and other antigens in the presence and absence of human CD4
20. Molecular analysis of the role of streptococcal pyrogenic exotoxin A (SPEA) in invasive soft-tissue infection resulting from Streptococcus pyogenes
21. Streptococcal pyrogenic exotoxin A (SPEA) release, distribution and role in a murine model of fasciitis and multiorgan failure due to Streptococcus pyogenes
22. Evaluation of antibody crossreactivity in mouse tissues: Study of a panel of antibodies reacting to human antigens
23. Bacterial superantigen-induced human lymphocyte responses are nitric oxide-dependent and mediated by IL-12 and IFN-gamma
24. Activation of murine T cells by streptococcal pyrogenic exotoxin type A
25. Cell and receptor requirements for streptococcal pyrogenic exotoxin T-cell mitogenicity
26. The CD8 T cell response to staphylococcal enterotoxins
27. Human CD4 and human major histocompatibility complex class II (DQ6) transgenic mice: Supersensitivity to superantigen-induced septic shock
28. Toxic shock syndrome associated with phage-group 1 staphylococci
29. Rapid clearance of the bacterial superantigen staphylococcal enterotoxin B in vivo
30. The toxicity of staphylococcal enterotoxin B in mice is mediated by T cells
31. Expression of the cloned toxic shock syndrome toxin-1 gene (tst) in vivo with a rabbit uterine model
32. Analysis of toxicity of streptococcal pyrogenic exotoxin A mutants
33. Structures of five mutants of toxic shock syndrome toxin-1 with reduced biological activity
34. Galactosamine-induced sensitization to the lethal effects of endotoxin
35. T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: Critical role of tumor necrosis factor
36. Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of gram-positive bacteria
37. The liver eliminates T cells undergoing antigen-triggered apoptosis in vivo
38. The appearance of T cells bearing self-reactive T cell receptor in the livers of mice injected with bacteria
39. Toxic shock syndrome: Clinical, laboratory, and pathologic findings in fatal cases